RECENT NEWS

£21 million is being allocated to 64 NHS trusts across England to roll out AI tools to speed up the diagnosis and treatment of lung cancer.

The government will meet its target to open 160 community diagnostic centres a year early, the Health and Social Care Secretary has announced. All 160 centres will be open by March 2024, a year ahead of the original March 2025 target - speeding up access to potentially lifesaving tests and checks.

Four trusts in the Greater Manchester Pathology Network are working to deploy Clinisys’ laboratory information management system (LIMS) in a way that will enable them to work more collaboratively and improve services for clinicians and patients.

UK-based health technology consultancy Health Tech Enterprise is proud to announce their participation at MEDICA 2023 to showcase their ground-breaking support services helping international MedTech innovators in accessing the EU and UK markets, as they launch a pioneering Net Zero modelling tool for healthcare.

A leading corporate services provider, NHS Shared Business Services (NHS SBS), has launched its inaugural ‘Sustainable Healthcare Recycling & Waste Management’ framework agreement designed to help the NHS meet net zero.

Bender UK has appointed a new sales director to help drive future growth of the company. Carl Fletcher is responsible for the management and development of the sales function that covers the main business areas of Healthcare, eMobility, Service Solutions, and Industry.

Despite national efforts to address inequity, the health and care system is not always meeting the needs of people with a learning disability when they are cared for in hospital, says a new report from the Health Services Safety Investigations Body (HSSIB).

The UK’s Health Ombudsman has warned that sepsis is still taking too many lives due to the same hospital failings we were seeing over ten years ago.

Five leading HealthTech innovators will be among the strong delegation of UK companies joining the Association of British HealthTech Industries (ABHI) at Global Health Exhibition in Saudi Arabia.

Researchers have developed an artificial intelligence (AI)–based tool for estimating a newly diagnosed cancer patient’s chances for surviving long term, according to a study presented at the American College of Surgeons (ACS) Clinical Congress 2023.

A new report published by NHS Blood and Transplant shows that an increased proportion of potential organ donors of Black and Asian heritage are showing their support by registering their decision to be a donor on the NHS Organ Donor Register, but the number of actual deceased donors fell last year (2022/23).

New analysis by the Health Foundation shows that, if current trends continue, the waiting list for routine hospital treatment (‘elective care’) in England could rise to over 8 million by next summer, regardless of whether NHS industrial action continues.

A new study predicts dementia cases in England and Wales will double to 1.7 million by 2040, exceeding previous forecasts by over 40%. The research, funded by the UK Economic and Social Research Council and published in The Lancet Public Health, indicates that dementia incidence decreased by 28.8% between 2002 and 2008. However, it increased again by 25.2% between 2008 and 2016.

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

The Care Quality Commission’s (CQC’s) annual 'State of Care' report has warned that a combination of the cost-of-living crisis and workforce pressures is risking ‘unfair care’ – where those who can afford to pay for treatment do so and those who can’t face longer waits and reduced access, with poorer outcomes for some.

Innovate UK, LifeArc, and Medicines Discovery Catapult (MDC) have joined forces to create PACE (Pathways to Antimicrobial Clinical Efficacy), a £30 million initiative supporting early-stage innovationagainst antimicrobial resistance (AMR) to save lives. PACE has announced its first funding call with up to £10 million available to support innovators developing new antimicrobials.

A landmark clinical trial has revealed promising benefits for patients with multiple chronic conditions and at elevated risk of needing urgent care, using artificial intelligence (AI) predictive models and supported through intensive nurse-led coaching.

Patients suffering slow heart rhythm in Essex are set to benefit after local surgeons implanted a new and innovative pacemaker. Staff based at the world-renowned Essex Cardiothoracic Centre (CTC), part of Mid and South Essex NHS Foundation Trust, carried out the country’s first procedure to place Abbott’s Aveir VR leadless pacemaker into a patient’s heart that suffers from a slower-than-normal rate.

Nuffield Health Parkside Hospital, in Wimbledon, London, has treated its first four patients with the da Vinci Xi surgical system, a leading robotic-assisted surgical system that enables consultant surgeons to perform with greater precision, with patients likely to experience less pain and faster recoveries after the robot-assisted surgery.

A first-of-its-kind modular cardiac centre built by Darwin Group in Basingstoke has led to a 20 per cent increase in angiogram procedures in its first year, with more than 2,700 patients being seen.